Canosa, Antonio http://orcid.org/0000-0001-5876-4079
Calvo, Andrea
Moglia, Cristina
Vasta, Rosario
Palumbo, Francesca
Solero, Luca
Di Pede, Francesca
Cabras, Sara
Arena, Vincenzo
Zocco, Grazia
Casale, Federico
Brunetti, Maura
Sbaiz, Luca
Gallone, Salvatore
Grassano, Maurizio
Manera, Umberto
Pagani, Marco
Chiò, Adriano
Funding for this research was provided by:
fondation thierry latran (INSPIRED Project, INSPIRED Project)
ministero della salute (RF-2016-02362405)
seventh framework programme (259867)
ministero dell’istruzione, dell’università e della ricerca (Joint Programme - Neurodegenerative Disease Research (Strength, ALS-Care and Brain-Mend projects), PRIN, grant 2017SNW5MB, Department of Excellence grant)
Article History
Received: 25 July 2021
Accepted: 20 December 2021
First Online: 25 January 2022
Declarations
:
: The sponsor organizations had no role in data collection and analysis and did not participate to writing and approving the manuscript. Funding sources had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: The study was approved by the ethical committee ‘Comitato Etico Interaziendale Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino.’ The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. All of the patients signed written informed consent. They did not receive any remuneration for participation.
: Antonio Canosa, Cristina Moglia, Rosario Vasta, Francesca Palumbo, Luca Solero, Francesca Di Pede, Sara Cabras, Vincenzo Arena, Grazia Zocco, Federico Casale, Maura Brunetti, Luca Sbaiz, Salvatore Gallone, Maurizio Grassano, Umberto Manera, Marco Pagani: no disclosures.Andrea Calvo has received a research grant from Cytokinetics.Adriano Chiò serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Biogen, Cytokinetics, Denali Therapeutics, Amylyx, and AveXis.